BrainsWay Announces First of its Kind Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS
false
בריינסוויי בע"מ
2
380
BRAINSWAY LTD
Corporation no:
513890764
10767
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
24/05/2021
www.isa.gov.il
www.tase.co.il
Reference:
2021-02-088803
Time of broadcast:
11:43
11:43
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
BrainsWay Announces First of its Kind Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS
BrainsWay_Announces_First_of_its_Kind_Coverage_Policy_by_Centene_for_the_Treatment_of_OCD_Utilizing_Deep_TMS_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
BWAY
Date of revision of form structure:
04/05/2021
Address:
הרטום
19
,
ירושלים
91451
,
Tel:
02-5813140
,
Fax:
02-5812517
E-mail address:
uri@Brainsway.com
Company site:
www.Brainsway.com
Previous names of reporting entity:
Name of the Signatory:
Levy Hadar
Position of Signatory in the reporting corporation:
Chief Financial Officer
Name of Employer Company:
Address:
Hartum Street, Bynet Building
19
,
Jerusalem
9777518
Telephone:
97225824030
Facsimile:
97225812517
E-mail:
hadarl@brainsway.com
1